Humedix Co., Ltd. (KOSDAQ:200670)
69,300
+1,000 (1.46%)
Sep 16, 2025, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 715.18 billion as of September 16, 2025. Its market cap has increased by 87.98% in one year.
Market Cap
715.18B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
71.89
Stock Price
69,300.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 715.18B, an increase of 220.70%. That is a compound annual growth rate of 11.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 704.86B | 61.84% |
Dec 30, 2024 | 435.54B | 24.67% |
Dec 28, 2023 | 349.36B | 38.28% |
Dec 29, 2022 | 252.65B | 12.18% |
Dec 30, 2021 | 225.21B | -0.11% |
Dec 30, 2020 | 225.47B | 2.25% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.88T |
Celltrion | 37.82T |
ALTEOGEN | 26.27T |
Yuhan | 8,955.07B |
SK Biopharmaceuticals | 8,692.77B |
Peptron | 7,152.29B |
PharmaResearch | 6,690.93B |
ABL Bio | 5,746.76B |